← All ClinCES conferencesKlinBiS × MedicReS · Istanbul 2027
ClinCES — Clinical Evidence SciencesISTANBUL 202727–30 May 2027Registration information →
Galata Tower and Judas tree blossoms
ISTANBUL 2027 · 27–30 May 2027

Poster and oral abstract submission guidelines

A call for abstracts across all clinical specialties · 27–30 May 2027

SUBMISSION DEADLINE · 28 FEBRUARY 2027

Abstract submission opens on 1 December 2026 and is free of charge. The submission system is not yet open; access will be announced here.

ABSTRACT GUIDELINES · 01

Call for abstracts and scope

The joint KlinBiS and MedicReS 20th Anniversary International Congress on Good Medical & Clinical Research takes place in Istanbul on 27–30 May 2027.

Submissions are welcome from all clinical specialties and related disciplines contributing to the generation, evaluation, interpretation and application of clinical evidence. Original studies, systematic reviews, meta-analyses, methodological studies and scientific observations from clinical practice may be submitted.

Clarity of the research question, appropriate methods, ethical conduct, reliable findings and contribution to clinical evidence guide assessment.

ABSTRACT GUIDELINES · 02

Eligible study types

Completed original studies, systematic reviews, meta-analyses, biostatistical and research methodology studies are considered for oral or poster presentation. Clinical trials, observational and real-world data studies, diagnostic accuracy and health services research are eligible.

Case reports and case series are primarily considered for posters. Research protocols and ongoing studies are assessed separately for poster presentation.

Protocols and ongoing studies must not be presented as completed research. State study status in the title or abstract and identify preliminary findings as provisional.

ABSTRACT GUIDELINES · 03

Selecting a scientific field

Select the clinical specialty and study type when submitting. For multidisciplinary research, identify a primary field and use keywords for other fields. The scientific committee may reassign the category for review or programme placement.

ABSTRACT GUIDELINES · 04

Submission language and sessions

Abstracts may be submitted in Turkish or English. KlinBiS Turkish scientific sessions take place on 28 May 2027; MedicReS English scientific sessions on 29–30 May. Turkish courses on 27 May require separate registration.

Present in the language of the assigned session. The date and language appear in the acceptance letter and final programme. Accepted Turkish abstracts must also provide an English title and abstract at the final-text stage for the CES abstract book. Authors are responsible for translation accuracy.

ABSTRACT GUIDELINES · 05

Title and author information

Titles must not exceed 25 words and must describe the study clearly and accurately, without unsupported claims or promotional language. Avoid abbreviations unless essential and prefer generic or scientific names to trade names.

Provide every author’s full name, institution, department, city and country, the corresponding author’s contact details, the presenting author and ORCID identifiers where available. Authorship must reflect scientific contribution. All authors must approve submission, author order and the final text.

Requests to add, remove or reorder authors after review must include a justification and approval from all affected authors.

ABSTRACT GUIDELINES · 06

Abstract format and length

The limit is 350 words excluding title, authors and affiliations, applied separately to each language where both are required. Include three to five keywords. Do not include tables, figures, images or references in the abstract; these may appear in the presentation. Define abbreviations at first use and exclude identifiable patient or participant information.

Original research and methods studies: Objective, Methods, Results, Conclusion. Describe design, setting, sample, key variables, outcomes and analysis. Provide numerical results, with effect sizes and confidence intervals where appropriate. Avoid relying solely on p-values. Conclusions must be supported by findings and respect design limitations.

Systematic reviews and meta-analyses: Objective, Methods, Results, Conclusion. State sources searched, search date, key eligibility criteria, number of studies, synthesis methods and protocol registration number if available.

Case reports and series: Introduction, Case or Case Series, Discussion and Conclusion. Explain educational value and contribution to clinical evidence, protect privacy and obtain required publication/presentation consent.

Research protocols: Objective, Planned Methods, Study Status, Expected Scientific Contribution. Do not report findings that do not exist. For completed studies, “Results will be presented at the congress” is insufficient.

ABSTRACT GUIDELINES · 07

Ethics and declarations

Authors are responsible for obtaining ethics approval, permissions and consent appropriate to the study. Declare the ethics committee, decision date and reference number, or a reason approval is not required, in fields separate from the abstract word limit.

Declare applicable study registration and identifier; funding and the nature of support; financial and non-financial conflicts; previous presentation/publication; and any AI tools, their purpose and contribution.

AI tools cannot be listed as authors. Authors remain responsible for data, text, analyses and references. Fabricated data, sources or analyses are not accepted.

ABSTRACT GUIDELINES · 08

Originality and prior presentation

Do not submit the same study under multiple titles or divide it into multiple abstracts without scientific justification. Disclose previous presentations, preprints or publications. Novelty and suitability for repeat presentation will be assessed.

ABSTRACT GUIDELINES · 09

Scientific review

Author and affiliation details are separated from the review text. Each abstract is assessed by two independent reviewers; a third review may resolve substantial disagreement. Reviewers with conflicts do not assess the abstract concerned.

Criteria include question clarity and importance, design and methods, adequacy of findings, consistency of conclusions with data, originality, contribution to clinical evidence, ethics and reporting quality. Statistical significance alone does not determine acceptance. Negative and inconclusive findings are assessed on merit.

Decisions may be oral acceptance, poster acceptance, revision or rejection. Author preference is considered; scientific review and programme capacity determine the final format. Submission or payment does not guarantee acceptance, oral presentation or publication.

ABSTRACT GUIDELINES · 10

Oral presentation guidelines

Oral presentations take place in person, with 6 minutes for presentation and 3 minutes for discussion. Session details are communicated through acceptance correspondence and the programme.

Presentation structure: title, authors and affiliations; funding and conflicts; question and objective; methods; key findings; limitations; conclusion and contribution to clinical evidence.

Slides must be legible, in the session language and suitable for the allotted time. File formats and delivery instructions will be sent separately. Notify presenter changes in advance; replacements must be authors and registered for the relevant day.

ABSTRACT GUIDELINES · 11

Poster presentation guidelines

Posters are presented in person, printed in A0 portrait format (84.1 × 118.9 cm). Technical instructions for boards and mounting will be announced separately.

Include title, authors, affiliations, objective, methods, findings, conclusion, key limitations, ethics/funding/conflict disclosures and abstract number. Use the session language, readable text, clear graphics and concise explanations.

Presenters must be at their posters during scheduled assessment and discussion. Mounting a poster alone does not constitute presentation. Presenters arrange printing and transport. Mounting, assessment and removal times will appear in the final programme.

ABSTRACT GUIDELINES · 12

Presentation limits and registration

Each person may present a maximum of two abstracts: one oral and one poster. They may co-author other studies. Each accepted abstract requires at least one presenting author to complete registration and payment for the assigned day.

Two-day pass holders must ensure their selected days match the presentation schedule. Course registration alone does not grant presentation rights. No separate oral or poster fee applies. MedicReS live-stream access does not include presentation rights; online presentations are not offered.

ABSTRACT GUIDELINES · 13

Publication in the CES congress abstract book

All accepted and presented poster and oral abstracts will be published in CES — Clinical Evidence Sciences as part of the congress abstract book. Publication is included in the presenting author’s congress registration; no additional abstract publication fee applies.

This is abstract publication, not a full research article or acceptance of a full manuscript in CES. No particular indexing status or academic score is guaranteed.

Unregistered, withdrawn or unpresented abstracts are not published. Actual presentation is verified against congress records before publication.

Visit The CES journal →
The CES — Clinical Evidence Sciences
THE CESClinical Evidence Sciences
ABSTRACT GUIDELINES · 14

Documentation

Acceptance letter: abstract number, title, authors and accepted format. Programme record: session, date, time and language. Presentation certificate: actual presenter, title and format. Attendance certificate: attendance meeting applicable conditions. Abstract-book record: title, authors, affiliations, abstract number and page.

Presentation certificates name the actual presenter. Co-authorship is documented in the acceptance letter and abstract book; non-presenting co-authors do not receive certificates implying they presented.

ABSTRACT GUIDELINES · 15

Academic applications

Assessment for associate professorship, promotion or other academic applications depends on the rules in force for the application period. The organiser supplies accurate, verifiable meeting, programme, acceptance, presentation and publication records; it does not guarantee points or application acceptance.

Documents identify national and international sessions, organisers and languages clearly. Presentations on different days of the joint congress are not automatically certified as separate meetings.

ABSTRACT GUIDELINES · 16

Abstract timeline

1 December 2026Abstract submission opens
28 February 2027Abstract submission deadline
15 March 2027Acceptance and presentation format notifications
22 March 2027Requested revisions due
31 March 2027Presenting-author registration and payment deadline at early rates
15 April 2027Abstract session programme published
15 May 2027General registration and payment close

All deadlines are at 23:59 Türkiye time. The presenting-author registration and payment deadline of 31 March is separate from the general closing date of 15 May. No on-site registration or payment is available.

Registration fees and conditions →

For abstract enquiries, contact AB Health Tech: info@abhealthtech.com